Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Validation of a manual ability questionnaire in patients with systemic sclerosis
Arthritis Care and Research , 05/12/09
Vanthuyne M et al. – Study demonstrates that the systemic sclerosis (SSc)-adapted ABILHAND questionnaire is a reliable, valid, reproducible, linear, and unidimensional measure to assess and followup on the manual ability of patients with SSc; therefore, it could become a useful additional tool in clinical trials to assess treatment efficacy.
Methods- Aim was to adapt and validate a manual ability questionnaire, the ABILHAND, in pts with SSc
- Its original version which includes 81 manual daily activities, was presented to 156 pts with SSc
- Pts provided their perceived difficulty in performing each manual activity as impossible, difficult, or easy
- Pts were reassessed 1 month later to test the reproducibility
- Concomitantly, they were clinically evaluated for their disease activity/severity
- Their functional ability was tested with the HAQ
- 26 selected items defined a unidimensional and linear measure of manual ability showed a continuous progression in their difficulty
- The item difficulty hierarchy was invariant across 12 patient-related factors
- The manual ability score was reproducible over time
- Manual ability was poorer in SSc pts with more severe disease, and was negatively correlated with the HAQ score
Today in Autoimmune/Heritable...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögrens syndrome
Arthritis & Rheumatism, 11/06/09
Vaccination, atherosclerosis and systemic lupus erythematosus
Lupus, 11/05/09
Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts
Arthritis & Rheumatism, 11/11/09
Sponsor
Article Search
Sponsor


See Latest Articles


